The Patent Finder

Lyotropic Therapeutics, Inc.

Also on record
Records under this name other than the patents Lyotropic Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Lyotropic Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,858,927Method for Protection of Peptides or Proteins Against Non-Enzymatic Deamidation
Lapsed on the fee record
Ended Oct 14, 2026 · High confidence
Lapsed on the fee recordEnded Oct 14, 2026High confidence
US 8,728,829Compositions for binding to assay substrata and methods of using
Lapsed on the fee record
Ended May 20, 2026 · USPTO record
Lapsed on the fee recordEnded May 20, 2026USPTO record
US 7,758,890Treatment Using Dantrolene
Formerly held
Term ended
Term ended Jun 30, 2025 · Medium confidence
Term endedTerm ended Jun 30, 2025Medium confidence
US 8,449,863Stabilized uncoated particles of reversed liquid crystalline phase materials
Lapsed on the fee record
Ended May 28, 2025 · USPTO record
Lapsed on the fee recordEnded May 28, 2025USPTO record
US 7,968,124Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use
Term ended
Term ended Jul 27, 2024 · USPTO record
Term endedTerm ended Jul 27, 2024USPTO record
US 9,394,339Stabilized Formulations of Peptides and Proteins Protecting Against Non-Enzymatic Degradation
Lapsed on the fee record
Ended Jul 19, 2024 · High confidence
Lapsed on the fee recordEnded Jul 19, 2024High confidence
US 8,128,905Stabilized uncoated particles of reversed liquid crystalline phase materials
Lapsed on the fee record
Ended Mar 6, 2024 · USPTO record
Lapsed on the fee recordEnded Mar 6, 2024USPTO record
US 8,128,906Stabilized uncoated particles of reversed liquid crystalline phase materials
Lapsed on the fee record
Ended Mar 6, 2024 · USPTO record
Lapsed on the fee recordEnded Mar 6, 2024USPTO record
US 6,991,809Particles with improved solubilization capacity
Term ended
Term ended Jul 19, 2023 · USPTO record
Term endedTerm ended Jul 19, 2023USPTO record
US 8,685,460Treatment Using Dantrolene
Term ended
Term ended Feb 15, 2023 · Medium confidence
Term endedTerm ended Feb 15, 2023Medium confidence
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited